| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.50B | +9.3% |
| Gross profit | ¥0.17B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | -149.1% |
| Gross margin | 34.1% | Net margin -2.8% |
| Revenue Q/Q | -8.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.33B | 65.9% |
| R&D | ¥0.02B | 3.4% |
| SG&A | ¥0.14B | 27.8% |
| Tax & other | ¥0.01B | 1.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
九典制药 ・ 阿石创 ・ 威唐工业 ・ 聚灿光电 ・ 精研科技 ・ 万隆光电 ・ 广哈通信 ・ 永福股份 ・ 英可瑞 ・ 凯伦股份 ・ *ST泉为 ・ 华信新材
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies